MicroRNA-3163 targets ADAM-17 and enhances the sensitivity of hepatocellular carcinoma cells to molecular targeted agents
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-3163 targets ADAM-17 and enhances the sensitivity of hepatocellular carcinoma cells to molecular targeted agents
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 10, Issue 10, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-10-14
DOI
10.1038/s41419-019-2023-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting slug-mediated non-canonical activation of c-Met to overcome chemo-resistance in metastatic ovarian cancer cells
- (2019) Linlin Chang et al. Acta Pharmaceutica Sinica B
- ARQ-197 enhances the antitumor effect of sorafenib in hepatocellular carcinoma cells via decelerating its intracellular clearance
- (2019) Xudong Gao et al. OncoTargets and Therapy
- Lymphoid enhancer-binding factor-1 promotes stemness and poor differentiation of hepatocellular carcinoma by directly activating the NOTCH pathway
- (2019) Shuo Fang et al. ONCOGENE
- A novel triazole NMK-T-057 induces autophagic cell death in breast cancer cells by inhibiting γ-secretase-mediated activation of Notch-signaling
- (2019) Amlan Das et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anlotinib, a novel small molecular tyrosine kinase inhibitor, suppresses growth and metastasis via dual blockade of VEGFR2 and MET in osteosarcoma
- (2019) Gangyang Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Hypomethylation‐mediated activation of cancer/testis antigen KK‐LC‐1 facilitates hepatocellular carcinoma progression through activating the Notch1/Hes1 signalling
- (2019) Zhiqiang Chen et al. CELL PROLIFERATION
- Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma
- (2019) David J. Pinato et al. BRITISH JOURNAL OF CANCER
- PTK2 promotes cancer stem cell traits in hepatocellular carcinoma by activating Wnt/β-catenin signaling
- (2019) Zhongyi Fan et al. CANCER LETTERS
- γ-Secretase and its modulators: Twenty years and beyond
- (2019) Weiming Xia NEUROSCIENCE LETTERS
- Novel urokinase-plasminogen activator inhibitor SPINK13 inhibits growth and metastasis of hepatocellular carcinoma in vivo
- (2019) Ling Wei et al. PHARMACOLOGICAL RESEARCH
- A patient-derived orthotopic xenograft (PDOX) nude-mouse model precisely identifies effective and ineffective therapies for recurrent leiomyosarcoma
- (2019) Zhiying Zhang et al. PHARMACOLOGICAL RESEARCH
- Targeting the crosstalks of Wnt pathway with Hedgehog and Notch for cancer therapy
- (2019) Sharmistha Chatterjee et al. PHARMACOLOGICAL RESEARCH
- A temperature-sensitive phase-change hydrogel of tamoxifen achieves the long-acting antitumor activation on breast cancer cells
- (2019) Du Meng et al. OncoTargets and Therapy
- PTPRB promotes metastasis of colorectal carcinoma via inducing epithelial-mesenchymal transition
- (2019) Xingyue Weng et al. Cell Death & Disease
- The γ-secretase inhibitor GSI-I interacts synergistically with the proteasome inhibitor bortezomib to induce ALK+ anaplastic large cell lymphoma cell apoptosis
- (2019) Qingxiu Dang et al. CELLULAR SIGNALLING
- The ATP-binding cassette transporter ABCF1 is a hepatic oncofetal protein that promotes chemoresistance, EMT and cancer stemness in hepatocellular carcinoma
- (2019) Sze Wai Fung et al. CANCER LETTERS
- A potential role of the renin-angiotensin-aldosterone system in epithelial-to-mesenchymal transition-induced renal abnormalities: Mechanisms and therapeutic implications
- (2019) Pitchai Balakumar et al. PHARMACOLOGICAL RESEARCH
- Pregnane X receptor mediates sorafenib resistance in advanced hepatocellular carcinoma
- (2018) Fan Feng et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Upregulation of lncRNA PlncRNA-1 indicates the poor prognosis and promotes glioma progression by activation of Notch signal pathway
- (2018) Xiaolong Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Transcriptional Regulation of the Warburg Effect in Cancer by SIX1
- (2018) Ling Li et al. CANCER CELL
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- Which is the best combination of TACE and Sorafenib for advanced hepatocellular carcinoma treatment? A systematic review and network meta-analysis
- (2018) Fan Feng et al. PHARMACOLOGICAL RESEARCH
- Triclosan treatment decreased the antitumor effect of sorafenib on hepatocellular carcinoma cells
- (2018) Man Wu et al. OncoTargets and Therapy
- A new apatinib microcrystal formulation enhances the effect of radiofrequency ablation treatment on hepatocellular carcinoma
- (2018) Hui Xie et al. OncoTargets and Therapy
- Game-changing restraint of Ros-damaged phenylalanine, upon tumor metastasis
- (2018) Geraldine Gueron et al. Cell Death & Disease
- Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells
- (2018) Yingshi Zhang et al. Cell Death & Disease
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A novel inhibitor of ADAM17 sensitizes colorectal cancer cells to 5-Fluorouracil by reversing Notch and epithelial-mesenchymal transition in vitro and in vivo
- (2018) Dan-Dan Li et al. CELL PROLIFERATION
- LncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR-128/CD151 pathway in hepatocellular carcinoma
- (2018) Peng-Fei Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- ETS-1 induces Sorafenib-resistance in hepatocellular carcinoma cells via regulating transcription factor activity of PXR
- (2018) Zhiyi Shao et al. PHARMACOLOGICAL RESEARCH
- Targeting molecular pathways in cancer stem cells by natural bioactive compounds
- (2018) Danila Cianciosi et al. PHARMACOLOGICAL RESEARCH
- MicroRNA-140-3p enhances the sensitivity of hepatocellular carcinoma cells to sorafenib by targeting pregnenolone X receptor
- (2018) Jiaqi Li et al. OncoTargets and Therapy
- Drug Resistance in Non-Small Cell Lung Cancer: A Potential for NOTCH Targeting?
- (2018) Venus Sosa Iglesias et al. Frontiers in Oncology
- Anti-PD-1 Antibody SHR-1210 Combined with Apatinib for Advanced Hepatocellular Carcinoma, Gastric, or Esophagogastric Junction Cancer: An Open-label, Dose Escalation and Expansion Study
- (2018) Jianming Xu et al. CLINICAL CANCER RESEARCH
- Effects of VEGFR1+ hematopoietic progenitor cells on pre-metastatic niche formation and in vivo metastasis of breast cancer cells
- (2018) Du Meng et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Estrogen-dependent DLL1-mediated Notch signaling promotes luminal breast cancer
- (2018) Sushil Kumar et al. ONCOGENE
- Therapy-induced enrichment of cancer stem-like cells in solid human tumors: Where do we stand?
- (2018) Sara R. Martins-Neves et al. PHARMACOLOGICAL RESEARCH
- Bax inhibitor 1 is a γ-secretase–independent presenilin-binding protein
- (2018) Shenjie Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- iNOS promotes CD24+CD133+ liver cancer stem cell phenotype through a TACE/ADAM17-dependent Notch signaling pathway
- (2018) Ronghua Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-645 targets urokinase plasminogen activator and decreases the invasive growth of MDA-MB-231 triple-negative breast cancer cells
- (2018) Du Meng et al. OncoTargets and Therapy
- A novel long-sustaining system of apatinib for long-term inhibition of the proliferation of hepatocellular carcinoma cells
- (2018) Yanli Wang et al. OncoTargets and Therapy
- Procaspase-3-activating compound 1 stabilizes hypoxia-inducible factor 1α and induces DNA damage by sequestering ferrous iron
- (2018) Feifei Li et al. Cell Death & Disease
- Long noncoding RNA ATB promotes the epithelial−mesenchymal transition by upregulating the miR-200c/Twist1 axe and predicts poor prognosis in breast cancer
- (2018) Rong-Hui Li et al. Cell Death & Disease
- LINE-1 ORF-1p enhances the transcription factor activity of pregnenolone X receptor and promotes sorafenib resistance in hepatocellular carcinoma cells
- (2018) Yan Chen et al. Cancer Management and Research
- Moving Breast Cancer Therapy up a Notch
- (2018) Erik W. J. Mollen et al. Frontiers in Oncology
- Synergistic Effects of NOTCH/γ-Secretase Inhibition and Standard of Care Treatment Modalities in Non-small Cell Lung Cancer Cells
- (2018) Venus Sosa Iglesias et al. Frontiers in Oncology
- Breast cancer stem cells: Biology and therapeutic implications
- (2018) Ramesh Butti et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Therapies for advanced stage hepatocellular carcinoma with macrovascular invasion or metastatic disease: A systematic review and meta-analysis
- (2017) Richard S. Finn et al. HEPATOLOGY
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Terfenadine combined with epirubicin impedes the chemo-resistant human non-small cell lung cancer both in vitro and in vivo through EMT and Notch reversal
- (2017) Li An et al. PHARMACOLOGICAL RESEARCH
- The EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasis
- (2017) Yingchun Liang et al. Cell Death & Disease
- miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14
- (2017) Quanbo Ji et al. Cell Death & Disease
- Current advances in the elimination of hepatitis B in China by 2030
- (2017) Shuye Zhang et al. Frontiers of Medicine
- Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents
- (2016) Hui Jia et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MiRNA153 Reduces Effects of Chemotherapeutic Agents or Small Molecular Kinase Inhibitor in HCC Cells
- (2015) Yan Chen et al. CURRENT CANCER DRUG TARGETS
- The global burden of liver disease: The major impact of China
- (2014) Fu-Sheng Wang et al. HEPATOLOGY
- LINE-1 ORF-1p functions as a novel HGF/ETS-1 signaling pathway co-activator and promotes the growth of MDA-MB-231 cell
- (2013) Qian Yang et al. CELLULAR SIGNALLING
- Rhamnetin and Cirsiliol Induce Radiosensitization and Inhibition of Epithelial-Mesenchymal Transition (EMT) by miR-34a-mediated Suppression of Notch-1 Expression in Non-small Cell Lung Cancer Cell Lines
- (2013) JiHoon Kang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Long interspersed nuclear element ORF-1 protein promotes proliferation and resistance to chemotherapy in hepatocellular carcinoma
- (2013) Fan Feng WORLD JOURNAL OF GASTROENTEROLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search